Decreased Expression of the CCAAT/enhancer Binding Protein Alpha Gene Involved in Hepatocyte Proliferation in Human Hepatocellular Carcinomas
Overview
Authors
Affiliations
CCAAT/enhancer binding protein alpha (C/EBPalpha), expressed at a high level in liver, plays an important role in proliferation and differentiation of hepatocytes. Previous studies showed that an expression level of the C/EBPalpha gene in hepatocytes was downregulated in response to proliferation signals and that forced expression of the C/EBPalpha gene in a number of cells caused cell cycle arrest. We compared the expression level of the C/EBPalpha gene in surgical specimens between hepatocellular carcinoma and non-tumorous regions of the same patients. In 9 out of 13 cases, the expression level in the tumors was decreased compared with that in corresponding non-tumorous regions. Transfection of the C/EBPalpha gene into C/EBPalpha-negative human hepatocellular carcinoma HLF cells, however, did not influence the rate of cell proliferation or cell cycle. Our present data suggest that the expression of the C/EBPalpha gene was downregulated in the majority of human hepatocellular carcinoma but the expression may not be directly associated with impaired proliferative activity of hepatocellular carcinoma cells.
Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma.
Zhao X, Reebye V, Hitchen P, Fan J, Jiang H, Saetrom P Oncogene. 2019; 38(18):3446-3457.
PMID: 30643190 DOI: 10.1038/s41388-018-0665-6.
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N Oncol Lett. 2018; 16(4):5243-5248.
PMID: 30250594 PMC: 6144932. DOI: 10.3892/ol.2018.9292.
Mi L, Hu K, Wen X, Sun J, Wu A, Wang M Am J Cancer Res. 2018; 8(8):1449-1465.
PMID: 30210916 PMC: 6129490.
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N Oncol Lett. 2017; 14(1):899-902.
PMID: 28693249 PMC: 5494728. DOI: 10.3892/ol.2017.6239.
CCAAT/enhancer-binding protein α decreases the viability of gastric cancer cells.
Tomizawa M, Shinozaki F, Motoyoshi Y, Sugiyama T, Yamamoto S, Ishige N Oncol Lett. 2017; 13(6):4322-4326.
PMID: 28599433 PMC: 5453173. DOI: 10.3892/ol.2017.5987.